Table 2.
Adjusted Cox models for all‐cause mortality and end stage renal disease.
| Variable | Death from any cause | End stage renal disease | ||
|---|---|---|---|---|
| HR (95% CI) | P‐value | HR (95% CI) | P‐value | |
| Age | 1.03 (1.02–1.04) | <0.001 | 0.97 (0.97–0.98) | <0.001 |
| Sex | ||||
| Female | ‐ | ‐ | ‐ | ‐ |
| Male | 1.47 (1.19–1.80) | <0.001 | 1.57 (1.22–2.02) | <0.001 |
| Race | ||||
| Black | ‐ | ‐ | ‐ | ‐ |
| White | 1.20 (0.96–1.49) | 0.11 | 0.37 (0.27–0.52) | <0.001 |
| HTN | 0.92 (0.65–1.30) | 0.65 | 3.46 (1.63–7.37) | 0.001 |
| T2D | 0.81 (0.66–1.01) | 0.06 | 2.85 (2.09–3.89) | <0.001 |
| CKD | 1.68 (1.34–2.11) | <0.001 | ‐ | ‐ |
Note: HTN indicates hypertension diagnosis. CKD was removed from the end stage renal disease analysis.
Abbreviations: CKD, chronic kidney disease; T2D, type 2 diabetes.